Finanzwire Finanzwire
Basculer en Français
11281 Companies
250642 Keywords
179295 Articles
136462 Press releases
Headlines Articles Press releases ABSCIENCES Remove
  1. Home
  2. Companies
  3. ABSCIENCES
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/17/2024 at 18:03, 2 years 5 months ago

    Correction of the Consolidated Accounts of AB Science for 2023

    Financial Results Research And Development Consolidated Accounts AB Science Accounting Correction
  • BRIEF

    published on 05/15/2024 at 20:21, 2 years 5 months ago

    Reduction in operational losses and significant advances in clinical development for AB Science in 2023

    Financial Results Clinical Development AB Science Masitinib Amyotrophic Lateral Sclerosis
  • PRESS RELEASE

    published on 05/15/2024 at 20:16, 2 years 5 months ago

    AB Science reports its revenues for the year 2023 and provides an update on its activities

    AB Science presents financial information for the year 2023, including clinical development updates and intellectual property strengthening. Consolidated operating loss decreased by 15.7% compared to 2022
    Financial Information Clinical Development Intellectual Property Operating Loss AB Science
    Logo of ABSCIENCES
Previous page
1 ... 7 8
Accesswire
  • Published on 11/04/2026 at 23:10, 8 hours 21 minutes ago

    Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast

  • Published on 11/04/2026 at 23:00, 8 hours 31 minutes ago

    Avino Reports Q3 2026 Financial Results

  • Published on 11/04/2026 at 23:00, 8 hours 31 minutes ago

    Viemed Healthcare Announces Third Quarter 2026 Financial Results

  • Published on 11/04/2026 at 22:15, 9 hours 16 minutes ago

    Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity

  • Published on 11/04/2026 at 22:05, 9 hours 26 minutes ago

    Stabilis Solutions Announces Third Quarter 2026 Results

View all ACCESSWIRE
EQS Group
  • Published on 11/05/2026 at 07:29, 2 minutes ago

    DEUTZ generates double-digit growth and significantly increases its profitability in the first nine months of 2026

  • Published on 11/05/2026 at 07:10, 21 minutes ago

    EvoNext Holdings SA makes available the consolidated financial statements of Ascend Sport Technology AG for the financial year 2025/26

  • Published on 11/05/2026 at 07:05, 26 minutes ago

    AI boom risks widening divide between rich and poor nations as major study from Ayre Think Tank reveals $360 billion divide

  • Published on 11/05/2026 at 07:05, 26 minutes ago

    PolyPeptide Group: Definitive end result of the public tender offer of Samsung Biologics Co., Ltd.

  • Published on 11/05/2026 at 07:05, 26 minutes ago

    EDAG Engineering Group AG: Profitability significantly improved in the first nine months of 2026

View all EQS
Les Echos
  • Published on 11/05/2026 at 07:00, 31 minutes ago

    Eurazeo’s European asset management platform continues to gain momentum, driven by sustained international fundraising

  • Published on 11/05/2026 at 07:00, 31 minutes ago

    Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%

  • Published on 11/04/2026 at 18:00, 13 hours 31 minutes ago

    The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026

  • Published on 11/04/2026 at 17:45, 13 hours 46 minutes ago

    October 2026

  • Published on 11/04/2026 at 17:44, 13 hours 47 minutes ago

    Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy